Japanese (NIKKEI) Pharma Industry Analysis
UpdatedFeb 03, 2023
DataAggregated Company Financials
Companies40
- 7D-4.2%
- 3M-6.5%
- 1Y8.9%
- YTD-0.6%
Over the last 7 days, the Pharma industry has remained flat, although notably Daiichi Sankyo Company declined by 6.7%. The past year has been better, since the industry has gained 14% in that time. Looking forward, earnings are forecast to grow by 15% annually.
Industry Valuation and Performance
Has the Japanese Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 03 Feb 2023 | JP¥36.0t | JP¥13.9t | JP¥1.4t | 19x | 25.3x | 2.6x |
| Sun, 01 Jan 2023 | JP¥37.6t | JP¥13.7t | JP¥1.3t | 18.3x | 27.9x | 2.8x |
| Tue, 29 Nov 2022 | JP¥40.0t | JP¥13.7t | JP¥1.3t | 19.3x | 29.6x | 2.9x |
| Thu, 27 Oct 2022 | JP¥38.7t | JP¥13.3t | JP¥1.4t | 17.7x | 27.3x | 2.9x |
| Sat, 24 Sep 2022 | JP¥36.0t | JP¥13.3t | JP¥1.4t | 17.4x | 25.1x | 2.7x |
| Mon, 22 Aug 2022 | JP¥37.0t | JP¥13.3t | JP¥1.4t | 17.9x | 25.9x | 2.8x |
| Wed, 20 Jul 2022 | JP¥37.6t | JP¥13.1t | JP¥1.5t | 19.7x | 25.7x | 2.9x |
| Fri, 17 Jun 2022 | JP¥33.3t | JP¥13.1t | JP¥1.5t | 17.5x | 22.8x | 2.5x |
| Sun, 15 May 2022 | JP¥34.5t | JP¥13.2t | JP¥1.4t | 16.4x | 24.1x | 2.6x |
| Tue, 12 Apr 2022 | JP¥35.9t | JP¥12.8t | JP¥1.5t | 20.4x | 23.2x | 2.8x |
| Thu, 10 Mar 2022 | JP¥31.9t | JP¥12.8t | JP¥1.5t | 18.3x | 20.6x | 2.5x |
| Sat, 05 Feb 2022 | JP¥33.4t | JP¥12.8t | JP¥1.6t | 18.3x | 21.5x | 2.6x |
| Mon, 03 Jan 2022 | JP¥34.2t | JP¥12.5t | JP¥1.6t | 18x | 21.5x | 2.7x |
| Wed, 01 Dec 2021 | JP¥34.3t | JP¥12.5t | JP¥1.6t | 8.5x | 21.6x | 2.7x |
| Fri, 29 Oct 2021 | JP¥36.1t | JP¥12.3t | JP¥1.5t | 17.4x | 23.5x | 2.9x |
| Sun, 26 Sep 2021 | JP¥38.8t | JP¥12.2t | JP¥1.5t | 18.8x | 25.9x | 3.2x |
| Tue, 24 Aug 2021 | JP¥36.9t | JP¥12.3t | JP¥1.5t | 17.6x | 24.6x | 3x |
| Wed, 30 Jun 2021 | JP¥37.4t | JP¥12.3t | JP¥1.5t | 18.1x | 24.9x | 3x |
| Sat, 03 Apr 2021 | JP¥38.1t | JP¥11.9t | JP¥1.4t | 19.1x | 26.8x | 3.2x |
| Tue, 05 Jan 2021 | JP¥38.9t | JP¥12.0t | JP¥1.3t | 21.8x | 29.3x | 3.2x |
| Fri, 09 Oct 2020 | JP¥38.1t | JP¥12.0t | JP¥1.2t | 24.5x | 30.9x | 3.2x |
| Thu, 02 Jul 2020 | JP¥39.9t | JP¥12.0t | JP¥1.3t | 24.1x | 30.1x | 3.3x |
| Sun, 05 Apr 2020 | JP¥33.6t | JP¥12.0t | JP¥1.2t | 20.6x | 27.1x | 2.8x |
Price to Earnings Ratio
29.4x
Current Industry PE
- Investors are relatively neutral on the Japanese Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 26.2x.
- The industry is trading close to its 3-year average PS ratio of 2.9x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 2.8% per year over the last three years.
- Revenues for these companies have grown 4.8% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Japanese Healthcare industry?
| JP Market | -0.51% | |
| Healthcare | -3.11% | |
| Pharma | -4.23% | |
| Pharma | -4.23% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 4502 Takeda Pharmaceutical | JP¥4.17k | 0.9% +JP¥57.5b | 23.3% | PE30.4x | |
| 4551 Torii Pharmaceutical | JP¥3.10k | 3.2% +JP¥2.7b | -0.3% | PE21.8x | |
| 4586 MedRx | JP¥153.00 | 12.5% +JP¥479.8m | 41.7% | PS479.8x | |
| 8095 Astena Holdings | JP¥415.00 | 0.2% +JP¥39.4m | 0.7% | PE28.2x |